34 results on '"Bagot, Catherine"'
Search Results
2. Post-COVID-19 illness and associations with sex and gender
3. Fitusiran prophylaxis in people with severe haemophilia A or haemophilia B without inhibitors (ATLAS-A/B): a multicentre, open-label, randomised, phase 3 trial
4. Long-term risk of relapse in immune-mediated thrombotic thrombocytopenic purpura and the role of anti-CD20 therapy
5. Long COVID and cardiovascular disease: a prospective cohort study
6. A multisystem, cardio-renal investigation of post-COVID-19 illness
7. The suboptimal fibrinolytic response in COVID‐19 is dictated by high PAI‐1
8. The bleeding phenotype in people with nonsevere hemophilia
9. Seroprevalence to adeno‐associated virus type 6 in people with hemophilia B from a UK adult cohort
10. Real‐world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the TRAIT study
11. Socioeconomic deprivation and illness trajectory in the Scottish population after COVID-19 hospitalization
12. Outcomes of total hip and knee arthroplasty in patients with haemophilia: A meta‐analysis of comparative studies and clinical practice recommendations
13. Thrombopoietin mimetic‐induced bone marrow fibrosis
14. Outcomes of total hip and knee arthroplasty in patients with haemophilia: A meta‐analysis of comparative studies and clinical practice recommendations.
15. A new population pharmacokinetic model for recombinant factor IX‐Fc fusion concentrate including young children with haemophilia B.
16. Fibrinogenolysis and fibrinolysis in Vaccine-induced Immune Thrombocytopenia and Thrombosis (VITT)
17. Mental health symptoms and illness trajectory following COVID-19 hospitalization: A cohort study.
18. Helen Cotton
19. Study of the efficacy and safety of parsaclisib in participants with primary warm autoimmune hemolytic anemia
20. Mental health symptoms and illness trajectory following COVID-19 hospitalization: A cohort study
21. Chapter 41 - Hemostasis and Thrombosis
22. Catastrophic venous and arterial thrombosis in a young female with cervical cancer.
23. Desmopressin for bleeding in non‐severe hemophilia A: Suboptimal use in a real‐world setting
24. 157 Multi-system investigation of covid-19 illness
25. Fitusiran, an Investigational siRNA Therapeutic Targeting Antithrombin for the Treatment of Hemophilia: First Results from a Phase 3 Study to Evaluate Efficacy and Safety in People with Hemophilia a or B without Inhibitors (ATLAS-A/B)
26. Post-COVID-19 illness trajectory: a multisystem investigation.
27. Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis
28. Mycophenolate Mofetil for First-Line Treatment of Immune Thrombocytopenia
29. Thrombopoietin mimetic‐induced bone marrow fibrosis.
30. List of Contributors
31. European principles of care for women and girls with inherited bleeding disorders.
32. Long-term risk of relapse in immune-mediated thrombotic thrombocytopenic purpura and the role of anti-CD20 therapy
33. Fitusiran, an Investigational siRNA Therapeutic Targeting Antithrombin for the Treatment of Hemophilia: First Results from a Phase 3 Study to Evaluate Efficacy and Safety in People with Hemophilia a or B withoutInhibitors (ATLAS-A/B)
34. Rapidly established guidelines for the diagnosis and management of vaccine-induced thrombocytopenia and thrombosis (VITT) - a double-edged sword?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.